80 FR 59828 - Notice of Intent To Grant Partially Exclusive License

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

Federal Register Volume 80, Issue 191 (October 2, 2015)

Page Range		59828-59829
FR Document		2015-24955

This notice is issued in accordance with 35 U.S.C. 209(e) and 37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant a partially-exclusive license in the United States to practice the invention described and claimed in U.S. Patent No. 7,623,972 for an invention entitled ``Detection of Presence of Chemical Precursors''; U.S. Patent No. 7,801,687 for an invention entitled ``Chemical Sensors Using Coated or Doped Carbon Nanotube Networks''; U.S. Patent No. 7,968,054 for an invention entitled ``Nanostructure Sensing and Transmission Of Gas Data''; and U.S. Patent No. 8,000,903 for an invention entitled ``Coated or Doped Carbon Nanotube Network Sensors as Affected by Environmental Parameters''; and ARC-16902-1 for an invention entitled ``Nanosensors for medical diagnosis''; and ARC- 16292-1 for an invention entitled ``Nanosensor/Cell Phone Hybrid for Detecting Chemicals and Concentrations,'' to The Medical Innovation Group, LLC, having its principal place of business at 416 Mount Airy Road, Basking Ridge, NJ 07920. The patent rights in this invention have been assigned to the United States of America as represented by the Administrator of the National Aeronautics and Space Administration. The prospective partially-exclusive license will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.

Federal Register, Volume 80 Issue 191 (Friday, October 2, 2015)

[Federal Register Volume 80, Number 191 (Friday, October 2, 2015)]
[Notices]
[Pages 59828-59829]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-24955]


=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice (15-086)]


Notice of Intent To Grant Partially Exclusive License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of intent to grant partially exclusive license.

-----------------------------------------------------------------------

SUMMARY: This notice is issued in accordance with 35 U.S.C. 209(e) and 
37 CFR 404.7(a)(1)(i). NASA hereby gives notice of its intent to grant 
a partially-exclusive license in the United States to practice the 
invention described and claimed in U.S. Patent No. 7,623,972 for an 
invention entitled ``Detection of Presence of Chemical Precursors''; 
U.S. Patent No. 7,801,687 for an invention entitled ``Chemical Sensors 
Using Coated or Doped Carbon Nanotube Networks''; U.S. Patent No. 
7,968,054 for an invention entitled ``Nanostructure Sensing and 
Transmission Of Gas Data''; and U.S. Patent No. 8,000,903 for an 
invention entitled ``Coated or Doped Carbon Nanotube Network Sensors as 
Affected by Environmental Parameters''; and ARC-16902-1 for an 
invention entitled ``Nanosensors for medical diagnosis''; and ARC-
16292-1 for an invention entitled ``Nanosensor/Cell Phone Hybrid for 
Detecting Chemicals and Concentrations,'' to The Medical Innovation 
Group, LLC, having its principal place of business at 416 Mount Airy 
Road, Basking Ridge, NJ 07920. The patent rights in this invention have 
been assigned to the United States of America as represented by the 
Administrator of the National Aeronautics and Space Administration. The 
prospective partially-exclusive license will comply with the terms and 
conditions of 35 U.S.C. 209 and 37 CFR 404.7.

DATES: The prospective partially exclusive license may be granted 
unless, within fifteen (15) days from the date of this published 
notice, NASA receives written objections including evidence and 
argument that establish that the grant of the license would not be 
consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.

[[Page 59829]]

Competing applications completed and received by NASA within fifteen 
(15) days of the date of this published notice will also be treated as 
objections to the grant of the contemplated partially exclusive 
license. Objections submitted in response to this notice will not be 
made available to the public for inspection and, to the extent 
permitted by law, will not be released under the Freedom of Information 
Act, 5 U.S.C. 552.

ADDRESSES: Objections relating to the prospective license may be 
submitted to Patent Counsel, Office of Chief Counsel, NASA Ames 
Research Center, Mail Stop 202A-4, Moffett Field, CA 94035-1000. (650) 
604-5104; Fax (650) 604-2767.

FOR FURTHER INFORMATION CONTACT:  Robert M. Padilla, Chief Patent 
Counsel, Office of Chief Counsel, NASA Ames Research Center, Mail Stop 
202A-4, Moffett Field, CA 94035-1000. (650) 604-5104; Fax (650) 604-
2767. Information about other NASA inventions available for licensing 
can be found online at http://technology.nasa.gov/.

Mark P. Dvorscak,
Agency Counsel for Intellectual Property.
[FR Doc. 2015-24955 Filed 10-1-15; 8:45 am]
 BILLING CODE 7510-13-P

59828 Federal Register / Vol. 80, No. 191 / Friday, October 2, 2015 / Notices

the Credit Suisse Affiliated QPAM, with Credit Suisse Affiliated QPAM fails to Signed at Washington, DC, this 25th day of
the exception of reasonable restrictions, satisfy a condition for relief under this September, 2015.
appropriately disclosed in advance, that exemption. A Credit Suisse Related Lyssa Hall,
are specifically designed to ensure QPAM will not fail to meet the terms of Director of Exemption Determinations,
equitable treatment of all investors in a this exemption solely because Credit Employee Benefits Security Administration,
pooled fund in the event such U.S. Department of Labor.
Suisse AG, a Credit Suisse Affiliated
withdrawal or termination may have QPAM, or a different Credit Suisse [FR Doc. 2015–24919 Filed 10–1–15; 8:45 am]
adverse consequences for all other Related QPAM fails to satisfy a BILLING CODE 4510–29–P
investors, provided that such condition for relief under this
restrictions are applied consistently and
exemption;
in like manner to all such investors; and NATIONAL AERONAUTICS AND
(5) not to impose any fees, penalties, or (o) ERISA-covered plans and IRAs
SPACE ADMINISTRATION
charges for such termination or with assets managed by Credit Suisse
withdrawal with the exception of Affiliated QPAMs in reliance of PTE 84– [Notice (15–086)]
reasonable fees, appropriately disclosed 14 must receive a copy of this final
in advance, that are specifically exemption no later than 90 days Notice of Intent To Grant Partially
designed to prevent generally following the date of publication in the Exclusive License
recognized abusive investment practices Federal Register. Notice to a plan or AGENCY: National Aeronautics and
or specifically designed to ensure IRA may be provided electronically Space Administration.
equitable treatment of all investors in a (including by an email that has a link to ACTION: Notice of intent to grant
pooled fund in the event such the exemption). partially exclusive license.
withdrawal or termination may have
adverse consequences for all other Section II: Definitions SUMMARY: This notice is issued in
investors, provided that such fees are accordance with 35 U.S.C. 209(e) and 37
applied consistently and in like manner (a) The term ‘‘Credit Suisse Affiliated
QPAM’’ means a ‘‘qualified professional CFR 404.7(a)(1)(i). NASA hereby gives
to all such investors. Within six (6) notice of its intent to grant a partially-
months of the date of publication of this asset manager’’ (as defined in section
exclusive license in the United States to
notice of exemption in the Federal VI(a) 14 of PTE 84–14) that relies on the
practice the invention described and
Register, each Credit Suisse Affiliated relief provided by PTE 84–14 and with
claimed in U.S. Patent No. 7,623,972 for
QPAM will provide a notice to such respect to which Credit Suisse AG is a
an invention entitled ‘‘Detection of
effect to each ERISA-covered plan or current or future ‘‘affiliate’’ (as defined Presence of Chemical Precursors’’; U.S.
IRA for which a Credit Suisse Affiliated in section VI(d) of PTE 84–14). The term Patent No. 7,801,687 for an invention
QPAM provides asset management or ‘‘Credit Suisse Affiliated QPAM’’ entitled ‘‘Chemical Sensors Using
other discretionary fiduciary services; excludes the parent entity, Credit Suisse Coated or Doped Carbon Nanotube
(l) Each Credit Suisse Affiliated AG. Networks’’; U.S. Patent No. 7,968,054
QPAM will maintain records necessary for an invention entitled ‘‘Nanostructure
(b) The term ‘‘Credit Suisse Related
to demonstrate that the conditions of Sensing and Transmission Of Gas Data’’;
QPAM’’ means any current or future
this exemption have been met for six (6) and U.S. Patent No. 8,000,903 for an
years following the date of any ‘‘qualified professional asset manager’’
(as defined in section VI(a) of PTE 84– invention entitled ‘‘Coated or Doped
transaction for which such Credit Suisse
14) that relies on the relief provided by Carbon Nanotube Network Sensors as
Affiliated QPAM relies upon the relief
PTE 84–14, and with respect to which Affected by Environmental Parameters’’;
in the exemption;
(m) The Credit Suisse Affiliated Credit Suisse AG owns a direct or and ARC–16902–1 for an invention
QPAMs provided a notice of the indirect five percent or more interest, entitled ‘‘Nanosensors for medical
proposed exemption along with a but with respect to which Credit Suisse diagnosis’’; and ARC–16292–1 for an
separate summary describing the facts AG is not an ‘‘affiliate’’ (as defined in invention entitled ‘‘Nanosensor/Cell
that led to the Conviction, which has Phone Hybrid for Detecting Chemicals
Section VI(d) of PTE 84–14).
been submitted to the Department, and and Concentrations,’’ to The Medical
(c) The term ‘‘Conviction’’ means the Innovation Group, LLC, having its
a prominently displayed statement that judgment of conviction against Credit
the Conviction results in a failure to principal place of business at 416
Suisse AG for one count of conspiracy Mount Airy Road, Basking Ridge, NJ
meet a condition in PTE 84–14 to: (1)
Each sponsor of an ERISA-covered plan to violate section 7206(2) of the Internal 07920. The patent rights in this
and each beneficial owner of an IRA Revenue Code in violation of Title 18, invention have been assigned to the
invested in an investment fund United States Code, Section 371, that United States of America as represented
managed by a Credit Suisse Affiliated was entered in the District Court for the by the Administrator of the National
QPAM, or the sponsor of an investment Eastern District of Virginia in Case Aeronautics and Space Administration.
fund in any case where a Credit Suisse Number 1:14–cr–188–RBS, on The prospective partially-exclusive
Affiliated QPAM acts only as a sub- November 21, 2014. license will comply with the terms and
advisor to the investment fund; (2) each conditions of 35 U.S.C. 209 and 37 CFR
entity that may be a Credit Suisse 404.7.
Related QPAM; and (3) each ERISA- DATES: The prospective partially
mstockstill on DSK4VPTVN1PROD with NOTICES

covered plan for which the New York exclusive license may be granted unless,
14 In general terms, a QPAM is an independent
Branch of Credit Suisse AG provides within fifteen (15) days from the date of
fiduciary that is a bank, savings and loan this published notice, NASA receives
fiduciary securities lending services;
association, insurance company, or investment
and written objections including evidence
adviser that meets certain equity or net worth
(n) A Credit Suisse Affiliated QPAM requirements and other licensure requirements and
and argument that establish that the
will not fail to meet the terms of this that has acknowledged in a written management grant of the license would not be
exemption solely because a Credit agreement that it is a fiduciary with respect to each consistent with the requirements of 35
Suisse Related QPAM or a different plan that has retained the QPAM. U.S.C. 209 and 37 CFR 404.7.

VerDate Sep<11>2014 20:43 Oct 01, 2015 Jkt 238001 PO 00000 Frm 00109 Fmt 4703 Sfmt 4703 E:\FR\FM\02OCN1.SGM 02OCN1

Federal Register / Vol. 80, No. 191 / Friday, October 2, 2015 / Notices 59829

Competing applications completed and performance by the supervisor, along 8:35 a.m.–11:00 a.m.: SHINE
received by NASA within fifteen (15) with any response by the senior Construction Permit Application (Open/
days of the date of this published notice executive, and make recommendations Closed) - The Committee will hear
will also be treated as objections to the to the appointing authority relative to presentations by and hold discussions
grant of the contemplated partially the performance of the senior executive. with representatives of the NRC staff
exclusive license. Objections submitted The following persons have been and SHINE regarding the safety
in response to this notice will not be selected to serve on the Performance evaluation associated with the SHINE
made available to the public for Review Board of the National construction permit application for a
inspection and, to the extent permitted Endowment for the Arts (NEA): Mo99 medical radioisotope production
by law, will not be released under the Winona Varnon—Deputy Chairman for facility under 10 CFR part 50.
Freedom of Information Act, 5 U.S.C. Management and Budget Note: A portion of this meeting may be
552. Michael Griffin—Chief of Staff closed in order to discuss and protect
ADDRESSES: Objections relating to the Sunil Iyengar—Director, Research & information designated as proprietary
prospective license may be submitted to Analysis pursuant to 5 U.S.C. 552b(c)(4).
Patent Counsel, Office of Chief Counsel, Dated: September 28, 2015. 1:00 p.m.–3:30 p.m.: Interim Staff
NASA Ames Research Center, Mail Stop Kathy N. Daum, Guidance (ISG): Acute Chemical
202A–4, Moffett Field, CA 94035–1000. Exposures and Quantitative Standards
Director, Administrative Services.
(650) 604–5104; Fax (650) 604–2767. (Open)—The Committee will hear
[FR Doc. 2015–24963 Filed 10–1–15; 8:45 am]
FOR FURTHER INFORMATION CONTACT: presentations by and hold discussions
BILLING CODE P
Robert M. Padilla, Chief Patent Counsel, with representatives of the NRC staff,
Office of Chief Counsel, NASA Ames NEI, and other members of the public
Research Center, Mail Stop 202A–4, NUCLEAR REGULATORY regarding the Interim Staff Guidance
Moffett Field, CA 94035–1000. (650) COMMISSION (ISG): Acute Chemical Exposures and
604–5104; Fax (650) 604–2767. Quantitative Standards.
Information about other NASA Advisory Committee on Reactor 3:30 p.m.–6:00 p.m.: Preparation of
inventions available for licensing can be Safeguards; Notice of Meeting ACRS Reports (Open)—The Committee
found online at http:// will discuss proposed ACRS reports on
technology.nasa.gov/. In accordance with the purposes of matters discussed during this meeting.
Sections 29 and 182b of the Atomic
Mark P. Dvorscak, Energy Act (42 U.S.C. 2039, 2232b), the Note: A portion of this meeting may be
Agency Counsel for Intellectual Property. closed in order to discuss and protect
Advisory Committee on Reactor information designated as proprietary
[FR Doc. 2015–24955 Filed 10–1–15; 8:45 am] Safeguards (ACRS) will hold a meeting pursuant to 5 U.S.C. 552b(c)(4).
BILLING CODE 7510–13–P on October 7–10, 2015, 11545 Rockville
Pike, Rockville, Maryland. Friday, October 9, 2015, Conference
Wednesday, October 7, 2015, Room T2–B1, 11545 Rockville Pike,
NATIONAL FOUNDATION ON THE Conference Room T2–B1, 11545 Rockville, Maryland
ARTS AND THE HUMANITIES Rockville Pike, Rockville, Maryland 8:30 a.m.–10:00 a.m.: Future ACRS
National Endowment for the Arts 2:00 p.m.–2:05 p.m.: Opening Activities/Report of the Planning and
Remarks by the ACRS Chairman Procedures Subcommittee (Open/
Senior Executive Service Performance (Open)—The ACRS Chairman will make Closed)—The Committee will discuss
Review Board opening remarks regarding the conduct the recommendations of the Planning
of the meeting. and Procedures Subcommittee regarding
ACTION: Notice. items proposed for consideration by the
2:05 p.m.–3:30 p.m.: Reactor
SUMMARY: This notice announces the Oversight Process (ROP) Enhancements Full Committee during future ACRS
membership of the National Endowment (Open)—The Committee will hear Meetings, and matters related to the
for the Arts (NEA) Senior Executive presentations by and hold discussions conduct of ACRS business, including
Service (SES) Performance Review with representatives of the NRC staff anticipated workload and member
Board (PRB). regarding proposed enhancements to the assignments.
DATES: Effective Date: September 28, ROP Process. Note: A portion of this meeting may be
2015. 3:30 p.m.–4:00 p.m.: Assessment of closed pursuant to 5 U.S.C. 552b(c)(2) and (6)
the Quality of Selected Research to discuss organizational and personnel
ADDRESSES: Send comments concerning matters that relate solely to internal
Projects (Open)—The Committee will
this notice to: National Endowment for personnel rules and practices of ACRS, and
discuss the quality of selected NRC
the Arts, 400 7th Street SW., information the release of which would
research projects.
Washington, DC 20506 constitute a clearly unwarranted invasion of
4:00 p.m.–6:00 p.m.: Preparation of personal privacy.
FOR FURTHER INFORMATION CONTACT:
ACRS Reports (Open)—The Committee
Craig McCord Sr. by telephone at (202) will discuss proposed ACRS reports on 10:00 a.m.–10:15 a.m.: Reconciliation
682–5473 or by email at mccordc@ matters discussed during this meeting. of ACRS Comments and
arts.gov. Recommendations (Open)—The
Thursday, October 8, 2015, Conference Committee will discuss the responses
mstockstill on DSK4VPTVN1PROD with NOTICES

SUPPLEMENTARY INFORMATION: 4314(c)(1)
through (5) of title 5, U.S.C., requires Room T2–B1, 11545 Rockville Pike, from the NRC Executive Director for
each agency to establish, in accordance Rockville, Maryland Operations to comments and
with regulations prescribed by the 8:30 a.m.–8:35 a.m.: Opening remarks recommendations included in recent
Office of Personnel Management, one or by the ACRS Chairman (Open)—The ACRS reports and letters.
more SES Performance Review Boards. ACRS Chairman will make opening 1:00 p.m.–2:00 p.m.: Meeting with
The Board shall review and evaluate the remarks regarding the conduct of the Commissioner Baran (Open)—The
initial appraisal of a senior executive’s meeting. Committee will meet with

VerDate Sep<11>2014 20:43 Oct 01, 2015 Jkt 238001 PO 00000 Frm 00110 Fmt 4703 Sfmt 4703 E:\FR\FM\02OCN1.SGM 02OCN1

Document Created: 2015-12-15 08:45:05
Document Modified: 2015-12-15 08:45:05

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Action		Notice of intent to grant partially exclusive license.
Dates		The prospective partially exclusive license may be granted unless, within fifteen (15) days from the date of this published notice, NASA receives written objections including evidence and argument that establish that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7. Competing applications completed and received by NASA within fifteen (15) days of the date of this published notice will also be treated as objections to the grant of the contemplated partially exclusive license. Objections submitted in response to this notice will not be made available to the public for inspection and, to the extent permitted by law, will not be released under the Freedom of Information Act, 5 U.S.C. 552.
Contact		Robert M. Padilla, Chief Patent Counsel, Office of Chief Counsel, NASA Ames Research Center, Mail Stop 202A-4, Moffett Field, CA 94035-1000. (650) 604-5104; Fax (650) 604- 2767. Information about other NASA inventions available for licensing can be found online at http://technology.nasa.gov/.
FR Citation		80 FR 59828